Effect Of L-lactic Acid On Calcium Absorption In Rats Fed Omeprazole.
O. Chonan, R. Takahashi, H. Yasui, M. Watanuki
Published 1998 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
We examined the effect of L-lactic acid on calcium absorption in male Wistar rats made achlorhydric by dietary omeprazole, a proton pump inhibitor. The dietary omeprazole intake (0.03 g/100 g of diet) increased the gastric pH and decreased the apparent calcium absorption ratio. Dietary famotidine (0.03 g/100 g of diet), an H2-receptor antagonist, and lower doses of omeprazole (0.005 or 0.01 g/100 g of diet) did not affect the gastric pH or the calcium absorption. In a second experiment, dietary lactic acid (0.5, 1.0, or 2.5 g/100 g of diet) increased the intestinal calcium absorption dose dependently in rats fed omeprazole (0.03 g/100 g of diet). The gastric pH was significantly decreased only in the rats fed higher doses of lactic acid (1.0, or 2.5 g/100 g of diet). In a third experiment, a dietary sour milk beverage containing lactic acid (0.5 g/100 g of diet) increased the intestinal calcium absorption, but did not affect the gastric pH in rats fed omeprazole (0.03 g/100 g of diet). Although the significance of gastric acid in terms of overall calcium absorption is not known, under the present experimental conditions, the inhibition of gastric acid secretion by dietary omeprazole decreased the apparent calcium absorption, and the dietary lactic acid prevented the calcium absorption in rats fed omeprazole.
This paper references
Contribution of Gastric Emptying to the Blood Ethanol-Lowering Effect of Acetic Acid
Satoshi Mochizuki (1990)
Theeffect offat on calcium absorption fromamixed mealinnormal subjects, patients withmalabsorptive disease, andpatients with apartial gastrectomy
John E. Agnew (1971)
Intestinal nitrogen and electrolyte movements following fermented milk ingestion in man.
Sylvain Mahé (1994)
Editorial . 1986 . Osteomalacia after gastrectomy
P Persson (1993)
Disturbances of mineral and bone metabolism following gastric antrectomy in the rat.
William Fries (1992)
Report of the American Institute of Nurtition ad hoc Committee on Standards for Nutritional Studies.
Calcium absorption and achlorhydria.
Robert Roy Recker (1985)
Biostatistical Analysis, 2nd ed, Prentice-Hall, Englewood Cliffs, NJ
JH Zur (1989)
The clinical importance of drug interactions with antiulcer therapy.
James C. Reynolds (1990)
Calcium absorbability from milk products, an imitation milk, and calcium carbonate.
Robert Roy Recker (1988)
Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase
Erik Fellenius (1981)
Effect of galactooligosaccharides on calcium absorption in rats.
Osamu Chonan (1995)
The effects of gastrectomy in animals
Andrew C. Ivy (1940)
Metabolic bone disease after gastrectomy.
Richard L. Eddy (1971)
Delayed gastric emptying rate as a potential mechanism for lowered glycemia after eating sourdough bread: studies in humans and rats using test products with added organic acids or an organic salt.
H. Liljeberg (1996)
Solubility and intestinal transit time limit calcium absorption in rats.
Danielle Pansu (1993)
Regulation of vitamin D and calcium metabolism after gastrectomy.
Lisbeth Nilas (1985)
Effect of lactic acid on postprandial plasma-glucose and -insulin responses in rats administered glucose solution
Kiyoshi Ebihara (1996)
The absorption of calcium carbonate.
Peter Ivanovich (1967)
Gastrectomy causes bone loss in the rat: is lack of gastric acid responsible?
Petra Persson (1993)
An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium.
G. Bo-Linn (1984)
This paper is referenced by
A Benefit–Risk Assessment of the Use of Proton Pump Inhibitors in the Elderly
Gwen M C Masclee (2014)
Hip fracture risk in patients with a diagnosis of pernicious anemia.
N. Merriman (2010)
Use of proton-pump inhibitors and their associated risks among frail elderly nursing home residents
Mariko Teramura-Grönblad (2010)
Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study.
H C Chiu (2010)
The Effects on Nutrition, Metabolism and Infection by Proton Pump Inhibitors: Unsafe Perspective
Bong Ki Cha (2011)
Inhibidores de bomba de protones y riesgo de osteoporosis
Mario Andrés Quintana Duque (2009)
Acid-suppressive medications and risk of fracture: an updated meta-analysis.
D. Cai (2015)
Growth performance, carcass characteristics and meat quality of Hanwoo steers fed fermented liquid whey inoculated with lactic acid bacteria
Tabasum Ahmed Sonia (2014)
Effects of rabeprazole on bone metabolic disorders in a gastrectomized rat model.
Yuki Yamasaki (2016)
Was geschieht mit unangemessenen Verordnungen von Protonen- pumpeninhibitoren nach Krankenhaus-Entlassung?
Innere Medizin (2011)
Effect of L-lactic acid on the absorption of calcium in gastrectomized rats.
Osamu Chonan (1998)
Proton pump inhibitors and calcium homeostasis
Miguel Martí-Cabrera (2013)
Adverse skeletal effects of drugs - beyond Glucocorticoids.
Susannah O'Sullivan (2015)
Development, carcass and meat qualities of Hanwoo steers fed fermented liquid when inoculated with lactic acid bacteria
Jun Ho Shin (2015)
Pharmacoepidemiologic Investigation of the Risk Factors Associated with Hypocalcemia Induced by Denosumab
Ryosuke Araki (2015)
Refractory hypocalcemia and hypomagnesemia associated with the use of an oral proton-pump inhibitor in a patient with hypoparathyroidism
Yea-Shin Lin (2015)
Effect of the Proton Pump Inhibitors on the Development of Hypocalcemia Induced by Denosumab
Ryosuke Araki (2017)
Safety of proton pump inhibitor exposure.
Y. Yang (2010)
Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
Edward Sheen (2010)
Chronic Proton Pump Inihibitor Therapy and Calcium Metabolism
Yu-Xiao Yang (2012)
The effect of a proton pump inhibitor on bone metabolism in ovariectomized rats.
Moon Kyung Joo (2013)
Atividade osteoclástica na superfície de hidroxiapatite nano e microestruturada modulada pela presença de inibidores da bomba de protões
Hélder Tiago Gomes Silva (2014)
Es real el riesgo de osteoporosis y riesgo de fracturas con el uso crónico de inhibidores de la bomba de protones
Miguel Martí-Cabrera (2011)
Hip Fracture Long-term Proton Pump Inhibitor Therapy and Risk of Correction
Y. Yang (2006)
Effect of omeprazole on the expression of transcription factors in osteoclasts and osteoblasts.
J. Hyun (2010)
[Chronic use of proton pump inhibitors: is the risk of osteoporosis and fractures real?].
Miguel Martí-Cabrera (2011)
Proton pump inhibitors and risk of osteoporosis
M. A. Duque (2009)
Association of Long-Term Proton Pump Inhibitor Therapy with Bone Fractures and Effects on Absorption of Calcium, Vitamin B12, Iron, and Magnesium
T. Ito (2010)
Potential adverse effects of proton pump inhibitors
G. Coté (2008)
EFECTOS A LARGO PLAZO DE LOS INHIBIDORES DE BOMBA DE PROTONES
Machín Lázaro (2012)
A Proton Pump Inhibitor’s Effect on Bone Metabolism Mediated by Osteoclast Action in Old Age: A Prospective Randomized Study
Yunju Jo (2015)
Chronic PPI Therapy and Calcium Metabolism
Yaning Yang (2015)See more